PUBLICATIONS

Our most recent publications are listed below.

A complete bibliography can be found on MyNCBI and ORCID.



PUBLICATIONS

Our most recent publications are listed below.

A complete bibliography can be found on MyNCBI and ORCID.


2021

Synthetic fluorescent MYC probe: Inhibitor binding site elucidation and development of a high-throughput screening assay. (2021) Shirey RJ, Hart JR, Sridharan B, Novick SJ, Turner LD, Zhou B, Nielsen AL, Eubanks LM, Ueno L, Hixon MS, Lairson LL, Spicer TP, Scampavia LD, Griffin PR, Vogt PK, Janda KD. Bioorg Med Chem 42:116246. PMID: 34130216


Stereo- and regio-defined DNA-encoded chemical libraries enable efficient tumour-targeting applications. (2021) Favalli N, Bassi G, Pellegrino C, Millul J, De Luca R, Cazzamalli S, Yang S, Trenner A, Mozzafari NL, Myburgh R, Moroglu M, Conway SJ, Sartori AA, Manz MG, Lerner RA, Vogt PK, Scheuermann J, Neri D. Nat Chem, 13(6):540-548. PMID: 33833446


2020


A single-stranded DNA-encoded chemical library based on a stereoisomeric scaffold enables ligand discovery by modular assembly of building blocks. (2020) Bassi G, Favalli N, Vuk M, Catalano M, Martinelli A, Trenner A, Porro A, Yang S, Tham CL, Moroglu M, Yue WW, Conway SJ, Vogt PK, Sartori AA, Scheuermann J, Neri D. Adv Sci, 7(22): 2001970. PMID: 33240760


An MXD1-derived repressor peptide identifies noncoding mediators of MYC-driven cell proliferation. (2020) Raffeiner P, Hart JR, García-Caballero D, Bar-Peled L, Weinberg MS, Vogt PK. Proc Nat Acad Sci USA, 117(12): 6571-9. PMID: 32156728

Available on the journal website.


2019


From Viruses to Genes to Cells. (2019) Vogt PK. Annu Rev Virol, 6(1): 31-47. PMID: 31567064

Available on the journal website.


PIK3CA Cooperates with KRAS to Promote MYC Activity and Tumorigenesis via the Bromodomain Protein BRD9. (2019) Bell CM, Raffeiner P, Hart JR, Vogt PK. Cancers (Basel), 11(11): 1634. PMID: 31652979

Available on the journal website.


The Importance of Being Non-Defective: A Mini Review Dedicated to the Memory of Jan Svoboda. (2019) Vogt PK. Viruses, 11(1): 80. PMID: 30669277

Available on the journal website.


2018


Isoform-specific activities of the regulatory subunits of phosphatidylinositol 3-kinases - potentially novel therapeutic targets. (2018) Ito Y, Hart JR, Vogt PK. Expert Opin Ther Targets, 22(10): 869-77. PMID: 30205700


Synthetic molecules for disruption of the MYC protein-protein interface. (2018) Jacob NT, Miranda PO, Shirey RJ, Gautam R, Zhou B, de Orbe Izquierdo ME, Hixon MS, Hart JR, Ueno L, Vogt PK, Janda KD. Bioorg Med Chem, 26(14): 4234-9. PMID: 30037753


2017


tsRNA signatures in cancer. (2017) Balatti V, Nigita G, Veneziano D, Drusco A, Stein GS, Messier TL, Farina NH, Lian JB, Tomasello L, Liu C-g, Palamarchuk A, Hart JR, Bell C, Carosi M, Pescarmona E, Perracchio L, Diodoro M, Russo A, Antenucci A, Visca P, Ciardi A, Harris CC, Vogt PK, Pekarsky Y, Croce CM. Proc Natl Acad Sci USA, 114(30): 8071-6. PMID: 28696308


Domain analysis reveals striking functional differences between the regulatory subunits of phosphatidylinositol 3-kinase (PI3K), p85α and p85β. (2017) Ito Y, Vogt PK, Hart JR. Oncotarget, 8(34): 55863-76. PMID: 28915558


2016


A butterfly effect in cancer. (2016) Vogt PK, Hart JR, Yates JR, 3rd. Mol Cell Oncol, 3(1): e1029063. PMID: 27308543


MINCR is not a MYC-induced lncRNA. (2016) Hart JR, Weinberg MS, Morris KV, Roberts TC, Janda KD, Garner AL, Vogt PK. Proc Natl Acad Sci USA, 113(5): E496-7. PMID: 26811502


A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling. (2016) Athuluri-Divakar SK, Vasquez-Del Carpio R, Dutta K, Baker SJ, Cosenza SC, Basu I, Gupta YK, Reddy MV, Ueno L, Hart JR, Vogt PK, Mulholland D, Guha C, Aggarwal AK, Reddy EP. Cell, 165(3): 643-55. PMID: 271980


2021

Synthetic fluorescent MYC probe: Inhibitor binding site elucidation and development of a high-throughput screening assay. (2021) Shirey RJ, Hart JR, Sridharan B, Novick SJ, Turner LD, Zhou B, Nielsen AL, Eubanks LM, Ueno L, Hixon MS, Lairson LL, Spicer TP, Scampavia LD, Griffin PR, Vogt PK, Janda KD. Bioorg Med Chem 42:116246. PMID: 34130216


Stereo- and regio-defined DNA-encoded chemical libraries enable efficient tumour-targeting applications. (2021) Favalli N, Bassi G, Pellegrino C, Millul J, De Luca R, Cazzamalli S, Yang S, Trenner A, Mozzafari NL, Myburgh R, Moroglu M, Conway SJ, Sartori AA, Manz MG, Lerner RA, Vogt PK, Scheuermann J, Neri D. Nat Chem, 13(6):540-548. PMID: 33833446


2020


A single-stranded DNA-encoded chemical library based on a stereoisomeric scaffold enables ligand discovery by modular assembly of building blocks. (2020) Bassi G, Favalli N, Vuk M, Catalano M, Martinelli A, Trenner A, Porro A, Yang S, Tham CL, Moroglu M, Yue WW, Conway SJ, Vogt PK, Sartori AA, Scheuermann J, Neri D. Adv Sci, 7(22): 2001970. PMID: 33240760


An MXD1-derived repressor peptide identifies noncoding mediators of MYC-driven cell proliferation. (2020) Raffeiner P, Hart JR, García-Caballero D, Bar-Peled L, Weinberg MS, Vogt PK. Proc Nat Acad Sci USA, 117(12): 6571-9. PMID: 32156728

Available on the journal website.


2019


From Viruses to Genes to Cells. (2019) Vogt PK. Annu Rev Virol, 6(1): 31-47. PMID: 31567064

Available on the journal website.


PIK3CA Cooperates with KRAS to Promote MYC Activity and Tumorigenesis via the Bromodomain Protein BRD9. (2019) Bell CM, Raffeiner P, Hart JR, Vogt PK. Cancers (Basel), 11(11): 1634. PMID: 31652979

Available on the journal website.


The Importance of Being Non-Defective: A Mini Review Dedicated to the Memory of Jan Svoboda. (2019) Vogt PK. Viruses, 11(1): 80. PMID: 30669277

Available on the journal website.


2018


Isoform-specific activities of the regulatory subunits of phosphatidylinositol 3-kinases - potentially novel therapeutic targets. (2018) Ito Y, Hart JR, Vogt PK. Expert Opin Ther Targets, 22(10): 869-77. PMID: 30205700


Synthetic molecules for disruption of the MYC protein-protein interface. (2018) Jacob NT, Miranda PO, Shirey RJ, Gautam R, Zhou B, de Orbe Izquierdo ME, Hixon MS, Hart JR, Ueno L, Vogt PK, Janda KD. Bioorg Med Chem, 26(14): 4234-9. PMID: 30037753


2017


tsRNA signatures in cancer. (2017) Balatti V, Nigita G, Veneziano D, Drusco A, Stein GS, Messier TL, Farina NH, Lian JB, Tomasello L, Liu C-g, Palamarchuk A, Hart JR, Bell C, Carosi M, Pescarmona E, Perracchio L, Diodoro M, Russo A, Antenucci A, Visca P, Ciardi A, Harris CC, Vogt PK, Pekarsky Y, Croce CM. Proc Natl Acad Sci USA, 114(30): 8071-6. PMID: 28696308


Domain analysis reveals striking functional differences between the regulatory subunits of phosphatidylinositol 3-kinase (PI3K), p85α and p85β. (2017) Ito Y, Vogt PK, Hart JR. Oncotarget, 8(34): 55863-76. PMID: 28915558


2016


A butterfly effect in cancer. (2016) Vogt PK, Hart JR, Yates JR, 3rd. Mol Cell Oncol, 3(1): e1029063. PMID: 27308543


MINCR is not a MYC-induced lncRNA. (2016) Hart JR, Weinberg MS, Morris KV, Roberts TC, Janda KD, Garner AL, Vogt PK. Proc Natl Acad Sci USA, 113(5): E496-7. PMID: 26811502


A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling. (2016) Athuluri-Divakar SK, Vasquez-Del Carpio R, Dutta K, Baker SJ, Cosenza SC, Basu I, Gupta YK, Reddy MV, Ueno L, Hart JR, Vogt PK, Mulholland D, Guha C, Aggarwal AK, Reddy EP. Cell, 165(3): 643-55. PMID: 271980